Serum anti-p53 autoantibodies from patients with idiopathic pulmonary fibrosis associated with lung cancer

被引:15
|
作者
Oshikawa, K [1 ]
Sugiyama, Y [1 ]
机构
[1] Jichi Med Sch, Dept Pulm Med, Minami Kawachi, Tochigi 3290498, Japan
关键词
p53; protein; mutation; oncogene; lung cancer; idiopathic interstitial pneumonia;
D O I
10.1053/rmed.2000.0917
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mutations of the tumour suppressor gene p53 lead to accumulation of the mutated p53 protein and subsequent production of antoantibodies against p53 proteins, which are also detected in lung cancer. Lung cancer is frequently associated with idiopathic pulmonary fibrosis (IPF). Therefore, we hypothesized that there might be a relationship between the p53 mutation and high prevalence of lung cancer in IPF. To test this hypothesis, we measured serum p53 antibody levels by an ELISA in various lung diseases including lung cancer (n=98), IPF (n=46; with lung cancer, n=14 and without lung cancer, n=32), pulmonary emphysema (PE, n=23) and healthy controls (HC, n=93). The median values of the serum anti-p53 antibody in each group were 8.78, 9.18, 8.08 and 4.95 for patients with lung cancer, IPF with lung cancer, IPF without lung cancer and PE, respectively, and 2.2 for the healthy control group. The groups of IPF (with and without lung cancer) showed a similar level of median values to the lung cancer group and a tendency for a higher level than the PE group. When the cut-off value was set at 7.7 according to the 95% specificity level for normal control, the incidence of positive anti-p53 antibody was significantly higher in lung cancer (61.2%), IPF with lung cancer (57.1%) and IPF without lung cancer (53.1%) than PE (21.7%). These results suggest that p53 mutations occur frequently and substantially in IPF, resulting in a high prevalence of lung cancer.
引用
收藏
页码:1085 / 1091
页数:7
相关论文
共 50 条
  • [1] Serum anti-p53 antibodies in patients with lung cancer
    Mack, U
    Ukena, D
    Montenarh, M
    Sybrecht, GW
    ONCOLOGY REPORTS, 2000, 7 (03) : 669 - 674
  • [2] Anti-p53 autoantibodies in colon cancer patients
    Sthoeger, Z
    Evron, E
    Goland, S
    Shani, A
    Wolkowicz, R
    Goldfinger, N
    Rotter, V
    Fogel, M
    B LYMPHOCYTES AND AUTOIMMUNITY, 1997, 815 : 496 - 498
  • [3] Serum anti-p53 autoantibodies in angiosarcoma
    Kiyohara, Mihoko
    Aoi, Jun
    Kajihara, Ikko
    Otuka, Saki
    Kadomatsu, Tuyoshi
    Fukushima, Satoshi
    Ihn, Hironobu
    JOURNAL OF DERMATOLOGY, 2020, 47 (08): : 849 - 854
  • [4] Serum anti-p53 autoantibodies in patients with type 1 diabetes
    Di Cesare, E
    Previti, M
    Lombardo, F
    Di Benedetto, A
    Mazzù, N
    Romano, G
    De Luca, F
    Lasco, A
    Cucinotta, D
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2001, 31 (03): : 253 - 258
  • [5] Anti-p53 autoantibodies in patients with IDDM
    Di Cesare, E
    Previti, M
    Lombardo, F
    Di Benedetto, A
    Romano, G
    De Luca, F
    Cucinotta, D
    DIABETOLOGIA, 1999, 42 : A97 - A97
  • [6] Anti-p53 autoantibodies in patients with schistosomiasis.
    Feil, G
    Petri, E
    Nelde, HJ
    Wechsel, HW
    Bichler, KH
    Knobloch, J
    JOURNAL OF UROLOGY, 1998, 159 (05): : 311 - 311
  • [7] Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases
    Neri, M
    Betta, P
    Marroni, P
    Filiberti, R
    Cafferata, M
    Mereu, C
    Ivaldi, G
    Montanaro, F
    Puntoni, R
    Paganuzzi, M
    LUNG CANCER, 2003, 39 (02) : 165 - 172
  • [8] Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients
    Lai, CL
    Tsai, CM
    Tsai, TT
    Kuo, BIT
    Chang, KT
    Fu, HT
    Perng, RP
    Chen, JY
    CLINICAL CANCER RESEARCH, 1998, 4 (12) : 3025 - 3030
  • [9] p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
    Schneider, J
    Presek, P
    Braun, A
    Bauer, P
    Konietzko, N
    Wiesner, B
    Woitowitz, HJ
    BRITISH JOURNAL OF CANCER, 1999, 80 (12) : 1987 - 1994
  • [10] p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
    J Schneider
    P Presek
    A Braun
    P Bauer
    N Konietzko
    B Wiesner
    H-J Woitowitz
    British Journal of Cancer, 1999, 80 : 1987 - 1994